Proteome Sciences (LON:PRM) Hits New 1-Year Low – What’s Next?

Proteome Sciences plc (LON:PRM) hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 1.31 and last traded at GBX 1.80, with a volume of 17592 shares changing hands. The stock had previously closed at GBX 1.76.

Proteome Sciences Stock Up 2.2%

The business has a 50 day simple moving average of GBX 2.40 and a 200 day simple moving average of GBX 2.84. The company has a market capitalization of £5.31 million, a price-to-earnings ratio of -1.59 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37.

Proteome Sciences (LON:PRM) last posted its quarterly earnings data on Thursday, September 25th. The company reported GBX (0.73) earnings per share (EPS) for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.